γ-Diketone neuropathy: Axon atrophy and the role of cytoskeletal protein adduction

Toxicology and Applied Pharmacology

Volumn 199, Issue 1, 2004, Pages 20-34

  LoPachin, Richard M ^a   DeCaprio, Anthony P ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY AT ALBANY   (United States)

Author keywords

diketone neuropathy; 2,5 Hexanedione; Axon atrophy; Axon swellings; Distal axonopathy; Neurofilament adduction

Indexed keywords

1,4 DIKETONE; ACETONYLACETONE;

ARTICLE; ATROPHY; CHEMICAL PROCEDURES; CONCENTRATION RESPONSE; CROSS LINKING; DORSAL ROOT; MUSCLE STRENGTH; MYELIN SHEATH; NERVE FIBER DEGENERATION; NERVOUS TISSUE; NEUROLOGIC DISEASE; NEUROPATHY; NEUROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PREVALENCE; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RUBROSPINAL TRACT; SKELETAL MUSCLE; SPINOCEREBELLAR TRACT; VENTRAL ROOT; X RAY MICROANALYSIS;

ANIMALS; ATROPHY; AXONS; CYTOSKELETAL PROTEINS; HEXANONES; NEUROFILAMENT PROTEINS; NEUROTOXINS; TIBIAL NERVE;

ANIMALIA;

EID: 4143089396     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2004.03.008     Document Type: Article

References (142)

1. Anderson R.J., Dunham C.B. Electrophysiological deficits in peripheral nerve as a discriminator of early hexacarbon neurotoxicity. J. Toxicol. Environ. Health. 13:1984;835-843
2. Anthony D.C., Giangaspero F., Graham D.G. The spatio-temporal pattern of the axonopathy associated with the neurotoxicity of 3,4-dimethyl-2,5-hexanedione in the rat. J. Neuropathol. Exp. Neurol. 42:1983;548-560
3. Anthony D.C., Boekelheide K., Graham D.G. The effect of 3,4-dimethyl substitution on the neurotoxicity of 2,5-hexanedione: I. Accelerated clinical neuropathy is accompanied by more proximal axonal swellings. Toxicol. Appl. Pharmacol. 71:1983;362-371
4. Baas P.W., Brown A. Slow axonal transport: the polymer transport model. Cell Biol. 7:1997;380-384
5. Braendgaard H., Sidenius P. Anterograde components of axonal transport in motor and sensory nerves in experimental 2,5-hexanedione neuropathy. J. Neurochem. 47:1986;31-37
6. Brown H.G., Hoh J.H. Entropic exclusion by neurofilament sidearms: a mechanism for maintaining interfilament spacing. Biochemistry. 36:1997;15035-15040
7. Brown M.J., DeJesus P.V., Pleasure D.E., Asbury A.K. Nerve conduction slowing precedes demyelination in experimental n-butyl ketone (MBK) neuropathy. Aguayo A., Kanpati G. Proceedings of the IVth International Congress on Neuromuscular Disease. 1978;276-301 Excerpta Medica, Amsterdam
8. Burek J.D., Albee R.R., Beyer J.E., Bell T.J., Carreon R.M., Morden D.C., Wade C.E., Hermann E.A., Gorzinski S.J. Subchronic toxicity of acrylamide administered to rats in drinking water followed by up to 144 days of recovery. J. Environ. Pathol. Toxicol. 4:1980;157-182
9. Carden M.J., Lee V.M.-Y., Schalepfer W.W. 2,5-Hexanedione neuropathy is associated with the covalent crosslinking of neurofilament proteins. Neurochem. Pathol. 5:1986;25-35
10. Cavanagh J.B. The pattern of recovery of axons in the nervous system of rats following 2,5-hexanediol intoxication: a question of rheology? Neuropathol. Appl. Neurobiol. 8:1982;19-34
11. Chen J., Nakata T., Zhang Z., Hirokawa N. The C-terminal tail domain of neurofilament protein-H NF-H forms the crossbridges and regulates neurofilament bundle formation. J. Cell Sci. 113:2000;3861-3869
12. Ching G.Y., Chien C.-L., Flores R., Liem R.K.H. Overexpression of a-internexin causes abnormal neurofilamentous accumulation and motor coordination deficits in transgenic mice. J. Neurosci. 19:1999;2974-2986
13. Chiu F.C., Opanashuk L.A., He D.K., Lehning E.J., LoPachin R.M. γ-Diketone peripheral neuropathy: II. Neurofilament subunit content. Toxicol. Appl. Pharmacol. 165:2000;141-147
14. Couri D., Milks M. Toxicity and the metabolism of the neurotoxic hexacarbons n-hexane, 2-hexanone and 2,5-hexanedione. Annu. Rev. Pharmacol. Toxicol. 22:1982;145-166
15. Davenport J.G., Farrell D.F., Sumi S.M. Giant axonal neuropathy caused by industrial chemicals: neurofilamentous axonal masses in man. Neurology. 26:1976;919-923
16. DeCaprio A.P. Molecular mechanisms of diketone neurotoxicity. Chem.-Biol. Interact. 54:1985;257-270
17. DeCaprio A.P. Mechanisms of in vitro pyrrole adduct autoxidation in 2,5-hexanedione-treated protein. Mol. Pharmacol. 30:1986;452-458
18. DeCaprio A.P. n-Hexane neurotoxicity. A mechanism involving pyrrole adduct formation in axonal cytoskeletal protein. Neurotoxicology. 8:1987;199-210
19. DeCaprio A.P. n-Hexane, metabolites and derivative. Spencer P.S., Schaumburg H.H. Experimental and Clinical Neurotoxicology. 2nd ed.:2000;633-648 Oxford Univ. Press, New York
20. DeCaprio A.P., Fowke J.H. Limited and selective adduction of carboxyl-terminal lysines in the high molecular weight neurofilament proteins by 2,5-hexanedione in vitro. Brain Res. 586:1992;219-228
21. DeCaprio A.P., O'Neill E.A. Alterations in rat axonal cytoskeletal proteins induced by in vitro and in vivo 2,5-hexanedione exposure. Toxicol. Appl. Pharmacol. 78:1985;235-247
22. DeCaprio A.P., Olajos E.J., Weber P. Covalent binding of a neurotoxic n-hexane metabolite: conversion of primary amines to substituted pyrrole adducts by 2,5-hexanedione. Toxicol. Appl. Pharmacol. 65:1982;440-450
23. DeCaprio A.P., Strominger N.L., Weber P. Neurotoxicity and protein binding of 2,5-hexanedione in the hen. Toxicol. Appl. Pharmacol. 68:1983;297-307
24. DeCaprio A.P., Jackowski S.J., Regan K.A. Mechanism of formation and quantitation of imines, pyrroles, and stable nonpyrrole adducts in 2,5-hexanedione-treated protein. Mol. Pharmacol. 32:1987;542-548
25. DeCaprio A.P., Briggs R.G., Jackowski S.J., Kim J.C.S. Comparative neurotoxicity and pyrrole-forming proteins of 2,5-hexanedione and perdeuterio-2,5-hexanedione in the rat. Toxicol. Appl. Pharmacol. 92:1988;75-85
26. DeCaprio A.P., Kinney E.A., Fowke J.H. Regioselective binding of 2,5-hexanedione to high-molecular-weight rat neurofilament proteins in vitro. Toxicol. Appl. Pharmacol. 145:1997;211-217
27. DeWaegh S.M., Lee V.M.-Y., Brady S.T. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell. 68:1992;451-463
28. Friede R.L., Samorajski T. Axon caliber related to neurofilaments and microtubules in sciatic nerve fibers of rats and mice. Anat. Rec. 167:1970;379-388
29. Fuchs E., Cleveland D.W. A structural scaffolding of intermediate filaments in health and disease. Science. 279:1998;514-519
30. Genter St. Clair M.B., Amarnath V., Moody M.A., Anthony D.C., Anderson C.W., Graham D.G. Pyrrole oxidation and protein cross-linking as necessary steps in the development of γ-diketone neuropathy. Chem. Res. Toxicol. 1:1988;179-185
31. Genter St. Clair M.B., Anthony D.C., Wikstrand C.J., Graham D.G. Pyrrole oxidation and protein cross-linking as necessary steps in the development of γ-diketone neuropathy. Neurotoxicology. 10:1989;743-756
32. Giasson B.I., Mushynski W.E. Study of proline-directed protein kinases involved in phosphorylation of the heavy neurofilament subunit. J. Neurosci. 17:1997;9466-9472
33. Glass J.D., Griffin J.W. Neurofilament redistribution in transected nerves: evidence for bi-directional transport of neurofilaments. J. Neurosci. 11:1991;3154-3164
34. Graham D.G., Anthony D.C., Boekelheide K., Maschmann N.A., Richards R.G., Wolfram J.W., Shaw B.R. Studies of the molecular pathogenesis of hexane neuropathy: II. Evidence that pyrrole derivitization of lysyl residues leads to protein crosslinking. Toxicol. Appl. Pharmacol. 64:1982;415-422
35. Graham D.G., Szakal-Quin G., Priest J.W., Anthony D.C. In vitro evidence that covalent crosslinking of neurofilaments occurs in γ-diketone neuropathy. Proc. Natl. Acad. Sci. 81:1984;4979-4982
36. Graham D.G., Genter St. Clair M.B., Amarnath V., Anthony D.C. Molecular mechanisms of γ-diketone neuropathy. Adv. Exp. Med. Biol. 283:1991;427-431
37. Graham D.G., Amarnath V., Valentine W.M., Pyle S.J., Anthony D.C. Pathogenetic studies of hexane and carbon disulfide neurotoxicity. Crit. Rev. Toxicol. 25:1995;91-112
38. Griffin J.W., Fahnestock K.E., Price D.L., Cork C. Cytoskeletal disorganization induced by local application of IDPN and 2,5-hexanedione. Ann. Neurol. 14:1983;55-61
39. Hirai T., Mizutani M., Kimura T., Ochiai K., Umemura T., Itakura C. Neurotoxic effects of 2,5-hexanedione on normal and neurofilament-deficient quail. Toxicol. Pathol. 27:1999;348-353
40. Hirai T., Mizutani M., Kimura T., Ochiai K., Umemura T., Itakura C. Distal axonopathy does not occur without neurofilament accumulation in g-diketone neuropathy: comparative studies of normal and neurofilament-deficient quail. Acta Neuropathol. 97:1999;552-556
41. Hirokawa N., Glickman M.A., Willard M.B. Organization of mammalian neurofilament polypeptides within the neuronal cytoskeleton. J. Cell Biol. 98:1984;1523-1536
42. Hirokawa N., Terada S., Funakoshi T., Takeda S. Slow axonal transport: the subunit transport model. Cell Biol. 7:1997;384388
43. Hisanaga S., Kusubata M., Okumura E., Kishimoto T. Phosphorylation of neurofilament H subunit at the tail domain by CDC2 kinase dissociates the association to microtubules. J. Biol. Chem. 266:1991;21798-21803
44. Hoffman P.N., Koo E.H., Muma N.A., Griffin J.W., Price D.L. Role of neurofilaments in the control of axonal caliber in myelinated nerve fibers. Lasek R.J., Black M.M. Intrinsic Determinants of Neuronal Form and Function. 1988;399-402 Alan R. Liss, New York
45. Horan K.I., Eichberg J., Berti-Mattera L.N., LoPachin R.M. Hexanedione effects on protein phosphorylation in rat peripheral nerve. Brain Res. 491:1989;366-370
46. Hsieh S.T., Kidd G.J., Crawford T.O., Xu Z., Lin W.M., Trapp B.D., Cleveland D.W. Regional modulation of neurofilament organization by myelination in normal axons. J. Neurosci. 14:1994;6392-6401
47. Jones H.B., Cavanagh J.B. The early evolution of neurofilamentous accumulations due to 2,5-hexanediol in the optic pathways of the rat. Neuropathol. Appl. Neurobiol. 8:1982;289-301
48. Jones H.B., Cavanagh J.B. Distortions of the nodes of Ranvier form axonal distension by filamentous masses in hexacarbon intoxication. J. Neurocytol. 12:1983;439-458
49. Jortner B.S., Ehrich M. Comparison of toxicities of acrylamide and 2,5-hexanedione in hens and rats on 3-week dosing regimens. J. Toxicol. Environ. Health. 39:1993;417-428
50. Jung C., Shea T.B. Regulation of neurofilament axonal transport by phosphorylation in optic axons in situ. Cell Motil. Cytoskeleton. 42:1999;230-240
51. Jung C., Yabe J.T., Wang F.-S., Shea T.B. Neurofilament subunits can undergo axonal transport without incorporation into triton-insoluble structures. Cell Motil. Cytoskeleton. 40:1998;44-58
52. Jung C., Yabe J.T., Shea T.B. C-terminal phosphorylation of the high molecular weight neurofilament subunit correlates with decreased neurofilament axonal transport velocity. Brain Res. 856:2000;12-19
53. Jung C., Yabe J.T., Lee S., Shea T.B. Hypophosphorylated neurofilament subunits undergo axonal transport more rapidly than more extensively phosphorylated subunits in situ. Cell Motil. Cytoskeleton. 47:2000;120-129
54. Karlsson J.-E., Rosengren L.E., Haglid K.G. Quantitative and qualitative alterations of neuronal and glial intermediate filaments in rat nervous system after exposure to 2,5-hexanedione. J. Neurochem. 57:1991;1437-1444
55. Kinney E.A., DeCaprio A.P. Comparative neurotoxicity and protein binding of 2,5-hexanedione and 3-acetyl-2,5-hexanedione in the rat. Toxicol. Sci. 60:2001;366
56. Klymkowsky M.W. Weaving a tangled web: the interconnected cytoskeleton. Nat. Cell Biol. 1:1999;E1212-E1223
57. Korobkin R., Asbury A.K., Sumner A.J., Nielsen S.L. Glue-sniffing neuropathy. Arch. Neurol. 32:1975;158-162
58. Krasavage W.J., O'Donoghue J.L., DiVincenzo G.D., Terhaar C.J. The relative neurotoxicity of methyl n-butyl ketone, n-hexane and their metabolites. Toxicol. Appl. Pharmacol. 52:1980;433-441
59. Kumar S., Yin X., Trapp B.D., Hoh J.H., Paulaitis M.E. Relating interactions between neurofilaments to the structure of axonal neurofilament distributions through polymer brush models. Biophys. J. 82:2002;2360-2372
60. Kuperman A.S. Effects of acrylamide on the central nervous system of the cat. J. Pharmacol. Exp. Ther. 123:1958;180-192
61. Kurita H. Experimental studies of n-hexane administration to albino rats. Jpn. J. Ind. Health. 9:1967;672-677
62. Lapadula D.M., Irwin R.D., Suwita E., Abou-Donia M.B. Cross-linking of neurofilament proteins of rat spinal cord in vivo after administration of 2,5-hexanedione. J. Neurochem. 46:1986;1843-1850
63. Lapadula D.M., Suwita E., Abou-Donia M.B. Evidence for multiple mechanisms responsible for 2,5-hexanedione-induced neuropathy. Brain Res. 458:1988;123-131
64. Lehning E.J., Dyer K.S., Jortner B.S., LoPachin R.M. Axonal atrophy is a specific component of 2,5-hexanedione peripheral neuropathy. Toxicol. Appl. Pharmacol. 135:1995;58-66
65. Lehning E.J., Jortner B.S., Fox J.H., Arezzo J.C., Kitano T., LoPachin R.M. γ-Diketone peripheral neuropathy: I. Quantitative morphometric analyses of axonal atrophy and swelling. Toxicol. Appl. Pharmacol. 165:2000;127-140
66. Leterrier J.F., Hartwig K.J., Vegners R., Janmey P.A. Mechanical effects of neurofilament cross-bridges. J. Biol. Chem. 271:1996;15687-15694
67. Lewis S.E., Nixon R.A. Multiple phosphorylated variants of the high molecular mass subunit of neurofilaments in axons of retinal cell neurons: characterization and evidence for their differential association with stationary and moving neurofilaments. J. Cell Biol. 107:1988;2689-2701
68. Li B.-S., Veeranna, Gu J., Grant P., Pant H.C. Activation of mitogen-activated protein kinases (Erk1 and Erk2) cascade results in phosphorylation of NF-M tail domains in transfected NIH 3T3 cells. Eur. J. Biochem. 262:1999;211-217
69. LoPachin R.M., Lehning E.J. The relevance of axonal swelling and atrophy to γ-diketone neurotoxicity. Neurotoxicology. 18:1997;7-22
70. LoPachin R.M., Lehning E.J., Stack E.C., Hussein S.J., Saubermann A.J. 2,5-Hexanedione alters elemental composition and water content of rat peripheral nerve myelinated axons. J. Neurochem. 63:1994;2266-2278
71. LoPachin R.M., Lehning E.J., Opanashuk L.A., Jortner B.S. Rate of neurotoxicant exposure determines morphological manifestations. Toxicol. Appl. Pharmacol. 167:2000;75-86
72. LoPachin R.M., Ross J.F., Reid M.L., Das S., Mansukhani S., Lehning E.J. Neurological evaluation of toxic axonopathies in rats: acrylamide and 2,5-hexanedione. Neurotoxicology. 23:2002;95-110
73. LoPachin R.M., Ross J.F., Lehning E.J. Nerve terminals as the primary site of acrylamide action: a hypothesis. Neurotoxicology. 23:2002;43-59
74. LoPachin R.M., Jortner B.S., Reid M.L., Das S. γ-Diketone central neuropathy: quantitative morphometric analysis of axons in rat spinal cord white matter regions and nerve roots. Toxicol. Appl. Pharmacol. 193:2003;29-46
75. LoPachin R.M., He D., Reid M.L., Opanashuk L.A. 2,5-Hexanedione-induced changes in the monomeric neurofilament protein content of rat spinal cord fractions. Toxicol. Appl. Pharmacol. 2003;. (in press)
76. LoPachin R.M., Balaban C.D., Ross J.F. Acrylamide axonopathy revisited. Toxicol. Appl. Pharmacol. 188:2003;135-153
77. Manetto V., Perry G., Tabaton M., Mulvihill P., Fried V.A., Smith H.T., Gambetti P., Autilio-Gambetti L. Ubiquitin is associated with abnormal cytoplasmic filaments characteristic of neurodegenerative diseases. Proc. Natl. Acad. Sci. 85:1988;4501-4505
78. Maxwell W.L., Povlishock J.T., Graham D.L. A mechanistic analysis of nondisruptive axonal injury: a review. J. Neurotrauma. 14:1997;419-440
79. Miyagaki H. An electrophysiological study on the toxicity of n-hexane on the peripheral nerve. Jpn. J. Ind. Health. 9:1967;660-671
80. Miyasaka H., Okabe S., Ishiguro K., Uchida T., Hirokawa N. Interaction of the tail domain of high molecular weight subunits of neurofilaments with the COOH-terminal region of tubulin and its regulation of τ protein kinase II. J. Biol. Chem. 268:1993;22695-22702
81. Monaco S., Autilio-Gambetti L., Zabel D., Gambetti P. Giant axonal neuropathy. Acceleration of neurofilament transport in optic axons. Proc. Natl. Acad. Sci. 82:1985;920-924
82. Monaco S., Simonati A., Rizzuto N., Autilio-Gambetti L., Gambetti P. Hexacarbon axonopathy: the morphological expression of altered cytoskeletal translocation. Nappi G. Neurodegenerative Disorders: The Role Played by Endotoxins and Xenobiotics. 1988;239-251 Raven Press, NY
83. Monaco S., Autilio-Gambetti L., Lasek R.J., Katz M.J., Gambetti P. Experimental increase of neurofilament transport rate: decreases in neurofilament number and in axon diameter. J. Neuropathol. Exp. Neurol. 48:1989;23-32
84. Monaco S., Jacob J., Jenich H., Autilio-Gambetti L., Gambetti P. Axonal transport of neurofilament is accelerated in peripheral nerve during 2,5-hexanedione intoxication. Brain Res. 491:1989;328-334
85. Monaco S., Wongmongkolrit T., Shearson C.M., Patton A., Schaetzle B., Autilio-Gambetti L., Gambetti P., Sayre L.M. Giant axonopathy characterized by intermediate location of axonal enlargements and acceleration of neurofilament transport. Brain Res. 519:1990;73-81
86. Moretto G., Monaco S., Passarin M.G., Benedetti M.D., Rizzuto N. Cytoskeletal changes induced by 2,5-hexanedione on developing human neurons in vitro. Arch. Toxicol. 65:1991;409-413
87. Muma N.A., Hoffman P.N. Neurofilaments are intrinsic determinants of axonal caliber. Micron. 24:1993;677-683
88. Nachtman J.P., Couri D. Biophysical and electrophysiological studies of hexanedione neurotoxicity. Neurotoxicology. 2:1981;541-556
89. Nakagawa T., Chen J., Zhang Z., Kanai Y., Hirokawa N. Two distinct functions of the carboxyl-terminal tail domain of NF-M upon neurofilament assembly: cross-bridge formation and longitudinal elongation of filaments. J. Cell Biol. 129:1995;411-429
90. Nixon R.A. Dynamic behavior and organization of cytoskeletal proteins in neurons: reconciling old and new findings. BioEssays. 20:1998;798-807
91. Nixon R.A., Logvinenko K.B. Multiple fates of newly synthesized neurofilament proteins: evidence for a stationary neurofilament network distributed nonuniformly along axons of retinal ganglion cell neurons. J. Cell Biol. 102:1986;647-659
92. Nixon R.A., Lewis S.E., Marotta C.A. Posttranslational modification of neurofilament proteins by phosphate during axoplasmic transport in retinal ganglion cell neurons. J. Neurosci. 7:1987;1145-1158
93. Nixon R.A., Paskevich P.A., Sihag R.K., Thayer C.Y. Phosphorylation on carboxyl terminus domains of neurofilament proteins in retinal ganglion cell neurons in vivo: influences on regional neurofilament accumulation, interneurofilament spacing and axon caliber. J. Cell Biol. 126:1994;1031-1046
94. Ochs S., Pourmand R., Jersild R.A., Friedman R.N. The origin and nature of beading: a reversible transformation of the shape of nerve fibers. Prog. Neurobiol. 52:1997;391-426
95. Ogawa Y., Komatsu T., Fujikake N., Fujii T., Tanaka J. Neurotoxic effects of 2,5-hexanedione on rapidly growing unmyelinated peripheral nerve axons of a rat fetus: dose-effect relationship. Environ. Res. 63:1993;287-295
96. Oh S.J., Kim J.M. Giant axonal swelling in "Huffer's" neuropathy. Arch. Neurol. 33:1976;583-586
97. O'Shaughnessy D.J., Losos G.J. Comparison of central and peripheral nervous system lesions caused by high-dose short-term and low-dose subchronic acrylamide treatment in rats. Toxicol. Pathol. 14:1986;389-394
98. Pant H., Veeranna C. Neurofilament phosphorylation. Biochem. Cell Biol. 73:1995;575-592
99. Pappolla M., Penton R., Weiss H.S., Miller C.H., Sahenk Z., Autilio-Gambetti L., Gambetti P. Carbon disulfide axonopathy. Another experimental model characterized by acceleration of neurofilament transport and distinct changes of axonal size. Brain Res. 424:1987;272-280
100. Pyle S.J., Amarnath V., Graham D.G., Anthony D.C. Alterations in neurofilament transport induced by 2,5-hexanedione and 3-acetyl-2,5-hexanedione. J. Neuropathol. Exp. Neurol. 51:1992;451-458
101. Pyle S.J., Amarnath V., Graham D.G., Anthony D.C. Decreased levels of the high molecular weight subunit of neurofilaments and accelerated neurofilament transport during the recovery phase of 2,5-hexanedione. Cell Motil. Cytoskeleton. 26:1993;133-143
102. Rizzuto N., Terzian H., Galiazzo-Rizzuto S. Toxic polyneuropathies in Italy due to leather cement poisoning in shoe industries. J. Neurol. Sci. 31:1977;343-354
103. Rosenberg C.K., Genter M.B., Szakal-Quin G., Anthony D.C., Graham D.G. d,l- versus meso-3,4-dimethyl-2,5-hexanedione: a morphometric study of the proximo-distal distribution of axonal swellings in the anterior root of the rat. Toxicol. Appl. Pharmacol. 87:1987;363-373
104. Rozman K.K., Doull J. Dose and time as variables of toxicity. Toxicology. 144:2000;169-178
105. Sakaguchi T., Okada M., Kitamura T., Kawasaki K. Reduced diameter and conduction velocity of myelinated fibers in the sciatic nerve of a neurofilament-deficient mutant quail. Neurosci. Lett. 153:1993;65-68
106. Sanchez I., Hassinger L., Sihag R.K., Cleveland D.W., Mohan P., Nixon R.A. Local control of neurofilament accumulation during radial growth of myelinating axons in vivo: selective role of site-specific phosphorylation. J. Cell Biol. 151:2000;1013-1024.2
107. Sayre L.M., Autilio-Gambetti L., Gambetti P. Pathogenesis of experimental giant neurofilamentous axonopathies: a unified hypothesis based on chemical modification of neurofilaments. Brain Res. Rev. 10:1985;69-83
108. Sayre L.M., Shearson C.M., Wongmongkolrit T., Medori R., Gambetti P. Structural basis of γ-diketone neurotoxicity: non-neurotoxicity of 3,3-dimethyl-2,5-hexanedione, a γ-diketone incapable of pyrrole formation. Toxicol. Appl. Pharmacol. 84:1986;36-44
109. Schaumburg H.H., Spencer P.S. Degeneration in central and peripheral nervous systems produced by pure n-hexane: an experimental study. Brain. 99:1976;183-192
110. Schaumburg H.H., Spencer P.S. Environmental hydrocarbons produce degeneration in cat hypothalamus and optic tract. Science. 199:1978;199-200
111. Shea T.B. Microtubule motors, phosphorylation and axonal transport of neurofilaments. J. Neurocytol. 29:2000;873-887
112. Shell L., Rozum M., Jortner B.S., Ehrich M. Neurotoxicity of acrylamide and 2,5-hexanedione in rats evaluated using a functional observational battery and pathological examination. Neurotoxicol. Teratol. 14:1992;273-283
113. Sickles D.W., Pearson J.K., Beall A., Testino A. Toxic axonal degeneration occurs independent of neurofilament accumulation. J. Neurosci. Res. 39:1994;347-354
114. Spencer P.S., Schaumburg H.H. Experimental neuropathy produced by 2,5-hexanedione - A major metabolite of the neurotoxic industrial solvent methyl n-butyl ketone. J. Neurol. Neurosurg. Psychiatry. 38:1975;771-775
115. Spencer P.S., Schaumburg H.H. Central-peripheral distal axonopathy - The pathology of dying-back polyneuropathies. Zimmerman H.M. Progress in Neuropathology. 1976;253-295 Grunne and Stratton, NY
116. Spencer P.S., Schaumburg H.H. Ultrastructural studies of the dying-back process: III. The evolution of experimental peripheral giant axonal degeneration. J. Neuropathol. Exp. Neurol. 36:1977;276-299
117. Spencer P.S., Schaumburg H.H. Ultrastructural studies of the dying-back process: IV. Differential vulnerability of PNS and CNS fibers in experimental central-peripheral distal axonopathies. J. Neuropathol. Exp. Neurol. 36:1977;300-319
118. Spencer P.S., Schaumburg H.H., Raleigh R.L., Terhaar C.J. Nervous system degeneration produced by the industrial solvent methyl n-butyl ketone. Arch. Neurol. 32:1975;219-222
119. Spencer P.S., Schaumburg H.H., Sabri M.I., Veronesi B. The enlarging view of hexacarbon neurotoxicity. CRC Crit. Rev. Toxicol. 7:1980;279-356
120. Spencer P.S., Couri D., Schaumburg H.H. n-Hexane and methyl n-butyl ketone. Spencer P.S., Schaumburg H.H. Experimental and Clinical Neurotoxicology. 1980;456-475 Williams and Wilkins, Baltimore, MD
121. Sterman A.B. Cell body remodeling during dying-back axonopathy: DRG changes during advanced disease. J. Neuropathol. Exp. Neurol. 41:1982;400-411
122. Sterman A.B. Hexacarbon neuropathy: cell body changes are early, dynamic and specific. Ann. Neurol. 16:1984;343-348
123. Sterman A.B., Delannoy M.R. Cell body responses to axonal injury: traumatic axotomy versus toxic neuropathy. Exp. Neurol. 89:1985;408-412
124. Stone J.D., Peterson A.P., Eyer J., Oblak J.G., Sickles D.W. Axonal neurofilaments are nonessential elements of toxicant-induced reductions in fast axonal transport: video-enhanced differential interference microscopy in peripheral nervous system axons. Toxicol. Appl. Pharmacol. 161:1999;50-58
125. Stone J.D., Peterson A.P., Eyer J., Sickles D.W. Neurofilaments are nonessential elements of toxicant-induced reductions in fast axonal transport: pulse labeling in CNS neurons. Neurotoxicology. 21:2000;447-458
126. Stone J.D., Peterson A.P., Eyer J., Oblak T.G., Sickles D.W. Neurofilaments are nonessential to the pathogenesis of toxicant-induced axonal degeneration. J. Neurosci. 21:2001;2278-2287
127. Svitkina T.M., Verkhovsky A.B., Borisy G.G. Plectin sidearms mediate interaction of intermediate filaments with microtubules and other components of the cytoskeleton. J. Cell Biol. 135:1996;991-1007
128. Terada M., Yasuda H., Kikkawa R., Koyama N., Yokota T., Shigeta Y. Electrophysiological study of dorsal column function in streptozotocin-induced diabetic rats: comparison with 2,5-hexanedione intoxication. J. Neurol. Sci. 115:1993;58-66
129. Truhaut R., Laget P., Piat G., Phu-Lich N., Dutertre-Catella H., Huyen V.N. Premiers resultats electrophysiologiques apres intoxications experimentales par l'hexne et par l'heptane techniques chez le rat blanc. Arch. Mal. Prof. Med. Trav. Secur. Soc. 34:1973;417-426
130. Tuckwell D.S., Laszlo L., Mayer R.J. 2,5-Hexanedione-induced intermediate filament aggregates contain ubiquitin-protein conjugate immunoreactivity and resemble Rosenthal fibres. Neuropathol. Appl. Neurobiol. 18:1992;593-609
131. Veeranna, Amin N.D., Ahn N.G., Jaffe H., Winters C.A., Pant P., Pant H.C. Mitogen-activated protein kinases (Erk1,2) phosphorylate Lys-Ser-Pro (KSP) repeats in neurofilament proteins NF-H and NF-M. J. Neurosci. 18:1998;4008-4021
132. Veeranna, Gu J., Shetty K.T., Takahashi M., Grant P., Pant H.C. Cdk5 and MAPK are associated with complexes of cytoskeletal proteins in rat brain. Mol. Brain Res. 76:2000;229-236
133. Watson D.F., Fittro K.P., Hoffman P.N., Griffin J.W. Phosphorylation- related immunoreactivity and the rate of transport of neurofilaments in chronic 2,5-hexanedione intoxication. Brain Res. 539:1991;103-109
134. Xu Z., Cork L.C., Griffin J.W., Cleveland D.W. Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell. 73:1993;23-33
135. Yabe J.T., Jung C., Chan W.K.-H., Shea T.B. Phospho-dependent association of neurofilament proteins with kinesin in situ. Cell Motil. Cytoskeleton. 45:2000;249-262
136. Yabe J.T., Chan W.K.-H., Chylinski T., Lee S., Pimenta A., Shea T.B. The predominant form in which neurofilament subunits undergo axonal transport varies during axonal initiation, elongation and maturation. Cell Motil. Cytoskeleton. 48:2000;61-83
137. Yabe J.T., Chylinski T., Wang F.-S., Pimenta A., Katter S.D., Linsley M.-D., Chan W.K.-H., Shea T.B. Neurofilaments consist of distinct population s that can be distinguished by C-terminal phosphorylation, bundling, and axonal transport rate in growing axonal neurites. J. Neurosci. 21:2001;2195-2205
138. Yagi Y. Effects of 2,5-hexanedione on rat spinal pyramidal tract. Jpn. J. Ind. Health. 36:1994;173-180
139. Yang Y., Bauer C., Strasser G., Wollman R., Julien J.-P., Fuchs E. Integrators of the cytoskeleton that stabilize microtubules. Cell. 98:1999;229-238
140. Yin X.H., Crawford T.O., Griffin J.W., Tu P.H., Lee V.M.-Y., Li C.M., Roder J., Trapp B.D. Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J. Neurosci. 18:1998;1953-1962
141. Yoshimura S., Imai K., Saitoh Y., Yamaguchi H., Ohtaki S. The same chemicals induce different neurotoxicity when administered in high doses for short term or low doses for long term to rats and dogs. Mol. Chem. Neuropathol. 16:1992;59-83
142. Zhu M., Spink D.C., Yan B., Bank S., DeCaprio A.P. Formation and structure of cross-linking and monomeric pyrrole autooxidation products in 2,5-hexanedione-treated amino acids, peptides and proteins. Chem. Res. Toxicol. 7:1994;551-558